Targeted cryptosporidium biocides
US8703134B2 · kind B2 · utility
2Cited by
31References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 6, 2013 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | Feb 6, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to fusion proteins comprising a microorganism targeting molecule (e.g., immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.